Extensions

Patent Term and Application History for U.S. Patent No. 11,969,333

As of May 14, 2026, the following information has been compiled regarding the application history and projected term for U.S. Patent No. 11,969,333 ("the '333 patent").

Continuity and Domestic Priority

The '333 patent is a continuation of a series of prior applications. The continuity chain, which establishes the patent's priority date, is as follows:

• This Patent: U.S. Patent No. 11,969,333, issued from application No. 18/329,450, filed on June 5, 2023.
• Is a continuation of: U.S. Patent No. 11,666,356, issued from application No. 17/741,495, filed on May 11, 2022.
• Which is a continuation of: U.S. Patent No. 11,331,114, issued from application No. 16/102,689, filed on August 13, 2018.

The earliest non-provisional filing date, which serves as the basis for the patent's 20-year term, is August 13, 2018.

Patent Term Adjustment (PTA)

The '333 patent has been granted a Patent Term Adjustment (PTA). PTA is awarded to compensate for administrative delays by the U.S. Patent and Trademark Office (USPTO) during the prosecution of a patent application. While the precise breakdown of the PTA calculation requires a detailed review of the patent's file history, public data indicates a total adjustment has been granted.

No Patent Term Extension (PTE), which is typically granted for delays in regulatory review by agencies such as the FDA, has been identified for this patent.

Projected Expiration Date

The standard 20-year term for a U.S. patent is calculated from its earliest non-provisional filing date.

• Earliest Filing Date: August 13, 2018
• Standard 20-Year Term End Date: August 13, 2038

Based on the publicly available data, the anticipated expiration date for the '333 patent is August 8, 2039. This indicates a total Patent Term Adjustment (PTA) of approximately 360 days has been added to the standard 20-year term. The final expiration date is subject to the timely payment of all required maintenance fees.